FDA Greenlights 'Breakthrough' Alzheimer's Drug Amid Risk and Cost Concerns

Leqembi, a breakthrough drug for Alzheimer's disease, as received the FDA’s nod for use, but medical experts caution about potential side effects, and call for training medical professionals before use.